Standardization of rubella immunoassays

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Rubella and congenital rubella are rare in countries with effective vaccination programs.
• Screening childbearing-aged women for rubella immunity is crucial for preventing congenital rubella syndrome.
• Rubella-specific IgG (RV-IgG) is the standard measure of immunity.

Purpose of the Study:

• To review factors influencing rubella virus (RV) immune status assessment.
• To address the lack of standardization in RV-IgG assays and its clinical implications.
• To examine the impact of vaccination programs and new technologies on RV infection epidemiology.

Main Methods:

• Literature review of factors affecting RV-IgG assay standardization.
• Analysis of epidemiological changes and technological advancements in RV immunity assessment.
• Evaluation of potential influences on rubella resurgence.

Main Results:

• Significant variability exists in RV-IgG assay standardization, yielding different IU/mL values for the same sample.
• This lack of standardization leads to result misinterpretation and potential adverse clinical outcomes.
• Current evidence does not link vaccination programs or new technologies to rubella resurgence.

Conclusions:

• Standardization of RV-IgG assays is critical for accurate interpretation of rubella immunity.
• Despite effective vaccination, ongoing monitoring and reliable testing are necessary.
• Further research is needed to ensure consistent and reliable assessment of rubella immunity.